Your browser doesn't support javascript.
loading
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
Boyle, Eileen M; Leleu, Xavier; Petillon, Marie-Odile; Karlin, Lionel; Doyen, Chantal; Demarquette, Hélène; Royer, Bruno; Macro, Margaret; Moreau, Philippe; Fostier, Karel; Marie-Lorraine, Chretien; Zarnitsky, Charles; Perrot, Aurore; Herbaux, Charles; Poulain, Stephanie; Manier, Salomon; Beauvais, David; Walker, Brian A; Wardell, Christopher P; Vincent, Laure; Frenzel, Laurent; Caillon, Hélène; Susanna, Schraen; Dejoie, Thomas; Avet-Loiseau, Hervé; Mohty, Mohamad; Facon, Thierry.
Afiliación
  • Boyle EM; Department of Haematology, Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Leleu X; Department of Haematology, Hôpital de la Miletrie, Poitiers University Hospital, Poitiers, France.
  • Petillon MO; Department of Haematology, Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Karlin L; Department of Haematology, Hôpital Lyon Sud, Lyon University Hospital, Pierre-Bénite, France.
  • Doyen C; Department of Haematology, CHU Dinant Godinne, UCL Namur, Yvoir, Belgium.
  • Demarquette H; Department of Haematology, Hospitalier Général, Dunkerque, France.
  • Royer B; Department of Haematology, Hôpital St Louis, Paris, France.
  • Macro M; Department of Haematology, CHRU Cote de Nacre, Caen University Hospital, Caen, France.
  • Moreau P; Department of Haematology, CHRU Hôtel Dieu, Nantes, University Hospital, Nantes, France.
  • Fostier K; Department of Haematology, UZ Brussel, Brussels, Belgium.
  • Marie-Lorraine C; Department of Haematology, University Hospital, Dijon, France.
  • Zarnitsky C; Department of Haematology, Centre Hospitalier J. Monod, CH du Havre, Le Havre, France.
  • Perrot A; Department of Haematology, Hôpitaux de Brabois, CHRU Nancy, Nancy, France.
  • Herbaux C; Department of Haematology, Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Poulain S; Service d'Hématologie Cellulaire, Centre de Biologie Pathologie, Lille University Hospital, Lille, France.
  • Manier S; INSERM UMRS 1172, Lille, France.
  • Beauvais D; Department of Haematology, Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Walker BA; Department of Haematology, Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Wardell CP; Myeloma Centre, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Vincent L; Myeloma Centre, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Frenzel L; Department of Haematology, CHU Montpellier, Montpellier, France.
  • Caillon H; Department of Clinical Haematology, AP-HP, Necker Hospital, Paris, France.
  • Susanna S; Department of Biochemistry, University Hospital of Nantes, Nantes, France.
  • Dejoie T; Department of Biochemistry, Biology Pathology Centre, Lille University Hospital, Lille, France.
  • Avet-Loiseau H; Department of Biochemistry, University Hospital of Nantes, Nantes, France.
  • Mohty M; Genomics of Myeloma Unit, University Hospital of Toulouse, Toulouse, France.
  • Facon T; Department of Haematology, Hôpital Saint Antoine, APHP, Paris, France.
Br J Haematol ; 187(3): 319-327, 2019 11.
Article en En | MEDLINE | ID: mdl-31218679
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Francia